Volume 44, Number 10
October 2015

Singapore Cancer Network (SCAN) Guidelines for Adjuvant Trastuzumab Use in Early Stage HER2 Positive Breast Cancer

Breast cancer is the most common malignancy among Singaporean females, with approximately 1700 new cases and 400 deaths per year in the period between...

Singapore Cancer Network (SCAN) Guidelines for Bisphosphonate Use in the Adjuvant Breast Cancer Setting

Breast cancer is the leading female cancer in our multiethnic Singaporean population and the most frequent cause of cancer mortality in females. The age-standardised...

Singapore Cancer Network (SCAN) Guidelines for Systemic Therapy of Colorectal Cancer

Globally, colorectal cancer (CRC) is the third most common cancer with 1 million new cases per year. In Singapore, CRC is the most common...

Singapore Cancer Network (SCAN) Guidelines for Systemic Therapy of Pancreatic Adenocarcinoma

Worldwide, pancreatic cancer is the thirteenth most common adult malignancy and the seventh most common cause of cancer death. In Singapore, it is the...

Singapore Cancer Network (SCAN) Guidelines for Systemic Therapy of Metastatic Renal Cell Carcinoma (mRCC)

Kidney cancer accounts for less than 1% of all cancers. There are over 200,000 new cases diagnosed with renal cell carcinoma (RCC) and over...